Self-Administered 2-Hour Oral Glucose Tolerance Test

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

May 1, 2025

Conditions
Gestational DiabetesPostpartum DisorderGestational Diabetes Mellitus in Pregnancy
Interventions
OTHER

Self-administered oral glucose tolerance test

Participants will be asked to self-administer the postpartum 75-gram oral glucose tolerance test. They will be provided the glucose solution and instructions. A 4 week virtual visit will be arranged where the test results will be reported to the provider and appropriate follow up arranged based on the results of their screen.

Trial Locations (1)

29605

Prisma Health/Greenville Memorial Hospital, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER

NCT06099509 - Self-Administered 2-Hour Oral Glucose Tolerance Test | Biotech Hunter | Biotech Hunter